Test Equipment

The next level in operating cost savings – the new high-power transmitter from Rohde & Schwarz

The R&S THU9evo UHF transmitter from Rohde & Schwarz represents the next level of development for the company’s successful family of high-power transmitters. The new transmitter comes with further improvements in both energy efficiency and power density, allowing network operators to achieve even greater operating cost savings. The R&S THU9evo delivers maximum energy savings even during channel changes or when adjusting the output power. The intelligent R&S Efficiency Optimization feature automatically provides the most economical operation possible for every operating scenario.

Rohde & Schwarz is committed to making network operatorsʹ lives easier. Over the years, the company has incorporated innovative ideas and concepts into transmitter development, and the new R&S THU9evo liquid-cooled UHF high-power transmitter represents the next step toward minimizing operating costs. Rohde & Schwarz was able to leverage its many years of experience in Doherty technology, which is the key to the new transmitter’s improved efficiency: up to 40 percent for COFDM standards and up to 43 percent for ATSC. The result is a reduction in energy consumption, which in turn lowers network operator costs. The transmitter delivers output powers from 1.5 kW to 96.5 kW for COFDM and from 1.65 kW to 106 kW for ATSC. At 17.4 kW (COFDM) and 19 kW (ATSC) per rack, it offers the highest power density on the market, which translates into enormous space savings.

The new R&S Efficiency Optimization feature minimizes energy costs for all types of operating scenarios. This feature proves its worth especially when adjusting output power or during channel changes. An intelligent algorithm, deployed at the press of a button or adaptively, optimizes amplifier parameters so that the transmitter achieves maximum energy efficiency at all times, resulting in the most economical system operation for every scenario.

The new R&S PHU903 high-power amplifier is the key to the excellent system efficiency. Unmatched by any other amplifier on the market, the R&S PHU903 provides maximum efficiency, combined with the capability to operate across the entire UHF range without any modifications. This is made possible by the R&S Multiband Doherty technology, which has been even further improved by Rohde & Schwarz. This technology ensures that network operators are optimally prepared for 700 MHz spectrum clearance and reallocation.

The new transmitter carries forward all of the proven strengths of the market-leading R&S THU9 platform. The R&S THU9evo retains the successful and proven R&S MultiTX concept along with the R&S Tx9 generation’s intuitive GUI, which is closely aligned with user requirements and work habits.

The R&S THU9evo liquid-cooled UHF high-power transmitter is now available from Rohde & Schwarz.

Liat

Recent Posts

Tower Semiconductor Secures $1.3 Billion Silicon Photonics Agreements and Reports Strong Q1 2026 Growth

Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…

3 days ago

14 Israeli Cybersecurity Companies Named to the Rising in Cyber 2026 List of the World’s Most Promising Cyber Startups

The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…

3 days ago

Sequent Selected by 15 Canadian Municipalities to Deliver Verifiable, Trust-Based Digital Voting for Elections

More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…

3 days ago

Sheba and Ichilov Medical Centers Join AccuLine’s International Clinical Trial for AI-Driven Early Heart Attack Risk Assessment

The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…

3 days ago

Molex Completes Acquisition of Teramount Ltd.

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…

7 days ago

Immunai Expands Oncology Collaboration, Extending AI-Driven Biomarker and Clinical Insights Through 2027

This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…

7 days ago